D.E. Shaw & Co’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-51,800
| Closed | -$4.14M | – | 4541 |
|
|
2024
Q4 | $4.14M | Buy |
+51,800
| New | +$4.48M | ﹤0.01% | 2134 |
|
|
2024
Q3 | – | Sell |
-40,000
| Closed | -$3.15M | – | 4750 |
|
|
2024
Q2 | $3.15M | Sell |
40,000
-210,700
| -84% | -$17.3M | ﹤0.01% | 2231 |
|
|
2024
Q1 | $21.8M | Buy |
250,700
+125,700
| +101% | +$10.7M | 0.02% | 877 |
|
|
2023
Q4 | $10.3M | Buy |
+125,000
| New | +$9.53M | 0.01% | 1338 |
|
|
2023
Q3 | – | Sell |
-50,000
| Closed | -$4.41M | – | 4391 |
|
|
2023
Q2 | $4.41M | Buy |
+50,000
| New | +$4.3M | ﹤0.01% | 1953 |
|
|
2023
Q1 | – | Sell |
-81,600
| Closed | -$6.34M | – | 4695 |
|
|
2022
Q4 | $6.34M | Buy |
81,600
+51,600
| +172% | +$4.18M | 0.01% | 1858 |
|
|
2022
Q3 | $2.42M | Sell |
30,000
-83,800
| -74% | -$7.53M | ﹤0.01% | 2823 |
|
|
2022
Q2 | $10.2M | Buy |
113,800
+12,700
| +13% | +$1.29M | 0.01% | 1372 |
|
|
2022
Q1 | $11.2M | Sell |
101,100
-68,900
| -41% | -$7.28M | 0.01% | 1500 |
|
|
2021
Q4 | $17.6M | Buy |
+170,000
| New | +$19.7M | 0.01% | 1183 |
|
|
2021
Q3 | – | Sell |
-11,300
| Closed | -$1.4M | – | 5111 |
|
|
2021
Q2 | $1.4M | Sell |
11,300
-3,700
| -25% | -$465K | ﹤0.01% | 3275 |
|
|
2021
Q1 | $1.77M | Sell |
15,000
-71,500
| -83% | -$8.38M | ﹤0.01% | 2687 |
|
|
2020
Q4 | $10.1M | Buy |
86,500
+40,000
| +86% | +$4.4M | 0.01% | 1378 |
|
|
2020
Q3 | $4.83M | Sell |
46,500
-13,500
| -23% | -$1.36M | ﹤0.01% | 1720 |
|
|
2020
Q2 | $5.5M | Sell |
60,000
-6,900
| -10% | -$662K | 0.01% | 1594 |
|
|
2020
Q1 | $6.03M | Buy |
+66,900
| New | +$7.12M | 0.01% | 1329 |
|
|
2019
Q2 | – | Sell |
-3,900
| Closed | -$355K | – | 3776 |
|
|
2019
Q1 | $355K | Buy |
+3,900
| New | +$349K | ﹤0.01% | 3153 |
|
|
2018
Q1 | – | Sell |
-2,600
| Closed | -$210K | – | 3658 |
|
|
2017
Q4 | $210K | Sell |
2,600
-5,100
| -66% | -$408K | ﹤0.01% | 3418 |
|
|
2017
Q3 | $599K | Buy |
7,700
+900
| +13% | +$74.7K | ﹤0.01% | 2815 |
|
|
2017
Q2 | $604K | Sell |
6,800
-14,400
| -68% | -$1.21M | ﹤0.01% | 2717 |
|
|
2017
Q1 | $1.71M | Buy |
21,200
+800
| +4% | +$62.5K | ﹤0.01% | 1941 |
|
|
2016
Q4 | $1.45M | Buy |
20,400
+10,700
| +110% | +$841K | ﹤0.01% | 2238 |
|
|
2016
Q3 | $838K | Buy |
+9,700
| New | +$845K | ﹤0.01% | 2506 |
|
|
2016
Q1 | – | Sell |
-144,955
| Closed | -$11.2M | – | 3636 |
|
|
2015
Q4 | $11.2M | Sell |
144,955
-18,500
| -11% | -$1.39M | 0.02% | 925 |
|
|
2015
Q3 | $10.9M | Sell |
163,455
-92,500
| -36% | -$6.81M | 0.02% | 914 |
|
|
2015
Q2 | $19M | Sell |
255,955
-40,000
| -14% | -$3.06M | 0.03% | 656 |
|
|
2015
Q1 | $23.1M | Sell |
295,955
-124,645
| -30% | -$9.45M | 0.04% | 553 |
|
|
2014
Q4 | $30.4M | Buy |
420,600
+110,000
| +35% | +$7.64M | 0.04% | 520 |
|
|
2014
Q3 | $19.2M | Buy |
310,600
+156,800
| +102% | +$9.97M | 0.02% | 720 |
|
|
2014
Q2 | $9.81M | Buy |
153,800
+10,800
| +8% | +$656K | 0.01% | 1117 |
|
|
2014
Q1 | $8.8M | Buy |
143,000
+65,400
| +84% | +$3.81M | 0.01% | 1134 |
|
|
2013
Q4 | $4.45M | Sell |
77,600
-21,000
| -21% | -$1.19M | 0.01% | 1782 |
|
|
2013
Q3 | $5.25M | Buy |
98,600
+67,500
| +217% | +$3.63M | 0.01% | 1551 |
|
|
2013
Q2 | $1.6M | Buy |
+31,100
| New | +$1.54M | ﹤0.01% | 2335 |
|
Other funds holding MDT
VCM
VPM
D.E. Shaw & Co's MDT Position: Q1 2026 in Review
D.E. Shaw & Co reduced its Medtronic (MDT) stake by 9.8% in Q1 2026, selling an estimated $9.29M and leaving 894,615 shares worth $77.5M. The position accounts for 0.05% of the portfolio, ranked #476.
D.E. Shaw & Co first reported a position in MDT in Q2 2013 and has held it in 50 quarters since. The position peaked at $519M in Q2 2019. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- D.E. Shaw & Co held 894,615 shares of Medtronic worth $77.5M as of Q1 2026.
- D.E. Shaw & Co sold 96,999 Medtronic shares in Q1 2026, an estimated $9.29M.
- Medtronic made up 0.05% of D.E. Shaw & Co's portfolio in Q1 2026, its #476 holding.
- D.E. Shaw & Co first reported a position in Medtronic in Q2 2013 and has held it in 50 quarters since.
- D.E. Shaw & Co's Medtronic position peaked at $519M in Q2 2019.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.